QQ客服 官方微博 反馈留言

	Modified citrus pectin inhibits galectin-3 function to reduce atherosclerotic lesions in apoE-deficient mice.
	Lu Y; Zhang M; Zhao P; Jia M; Liu B; Jia Q; Guo J; Dou L; Li J.
刊名	Mol Med Rep
	2017
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2003789
专题	河北省人民医院
作者单位	1.Neurology Department 2, Handan Central Hospital, Handan, Hebei 056001, P.R. China. 2.Clinical Laboratory, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China. 3.Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Beijing Hospital, Ministry of Health, Beijing 100730, P.R. China.
推荐引用方式 GB/T 7714	Lu Y,Zhang M,Zhao P,et al. Modified citrus pectin inhibits galectin-3 function to reduce atherosclerotic lesions in apoE-deficient mice.[J]. Mol Med Rep,2017.
APA	Lu Y.,Zhang M.,Zhao P.,Jia M.,Liu B.,...&Li J..(2017).Modified citrus pectin inhibits galectin-3 function to reduce atherosclerotic lesions in apoE-deficient mice..Mol Med Rep.
MLA	Lu Y,et al."Modified citrus pectin inhibits galectin-3 function to reduce atherosclerotic lesions in apoE-deficient mice.".Mol Med Rep (2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。